Induction of endoplasmic reticulum-endosome fusion for antigen cross-presentation induced by poly (γ-glutamic acid) nanoparticles

Journal of Immunology

Volumn 187, Issue 12, 2011, Pages 6249-6255

  Mukai, Yohei ^a   Yoshinaga, Tomoyo ^a   Yoshikawa, Mai ^a   Matsuo, Kazuhiko ^a   Yoshikawa, Tomoaki ^a   Matsuo, Keisuke ^a   Niki, Kazuyuki ^a   Yoshioka, Yasuo ^a   Okada, Naoki ^a   Nakagawa, Shinsaku ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD NANOPARTICLE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NANOPARTICLE; OVALBUMIN; POLY(GAMMA GLUTAMIC ACID)NANOPARTICLE; PROTEASOME; PROTEIN SEC61; TRANSLOCON; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOACCUMULATION; CELL COMPARTMENTALIZATION; CELL FUSION; CELL LEVEL; CELL VACUOLE; CONTROLLED STUDY; CROSS PRESENTATION; CYTOPLASM; DRUG DELIVERY SYSTEM; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; ENDOSOME; FEMALE; MOUSE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ANIMALS; CANCER VACCINES; CELLS, CULTURED; CROSS-PRIMING; ENDOPLASMIC RETICULUM; ENDOSOMES; FEMALE; H-2 ANTIGENS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; NANOPARTICLES; PHENYLALANINE; POLYGLUTAMIC ACID; VACCINES, DNA;

EID: 83755196115     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001093     Document Type: Article

References (49)

1. Berzofsky, J. A., M. Terabe, S. Oh, I. M. Belyakov, J. D. Ahlers, J. E. Janik, and J. C. Morris. 2004. Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J. Clin. Invest. 113: 1515-1525. (Pubitemid 39071672)
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252. (Pubitemid 28155090)
3. Huang, A. Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264: 961-965. (Pubitemid 24196166)
4. Nakagawa, S. 2008. [Efficacy and safety of poly (gamma-glutamic acid) based nanoparticles (gamma-PGA NPs) as vaccine carrier]. Yakugaku Zasshi 128: 1559-1565.
5. Akagi, T., M. Higashi, T. Kaneko, T. Kida, and M. Akashi. 2005. In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid). Macromol. Biosci. 5: 598-602. (Pubitemid 41020250)
6. Akagi, T., M. Higashi, T. Kaneko, T. Kida, and M. Akashi. 2006. Hydrolytic and enzymatic degradation of nanoparticles based on amphiphilic poly(gamma-glutamic acid)-graft-L-phenylalanine copolymers. Biomacromolecules 7: 297-303. (Pubitemid 43154506)
7. Akagi, T., T. Kaneko, T. Kida, and M. Akashi. 2005. Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier. J. Control. Release 108: 226-236. (Pubitemid 41608656)
8. Wang, X., T. Uto, T. Akagi, M. Akashi, and M. Baba. 2007. Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120. J. Virol. 81: 10009-10016. (Pubitemid 350067704)
9. Uto, T., X. Wang, K. Sato, M. Haraguchi, T. Akagi, M. Akashi, and M. Baba. 2007. Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J. Immunol. 178: 2979-2986. (Pubitemid 46333177)
10. Yoshikawa, T., N. Okada, A. Oda, K. Matsuo, K. Matsuo, H. Kayamuro, Y. Ishii, T. Yoshinaga, T. Akagi, M. Akashi, and S. Nakagawa. 2008. Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells. Vaccine 26: 1303-1313.
11. Yoshikawa, T., N. Okada, A. Oda, K. Matsuo, K. Matsuo, Y. Mukai, Y. Yoshioka, T. Akagi, M. Akashi, and S. Nakagawa. 2008. Development of amphiphilic gamma-PGA-nanoparticle based tumor vaccine: potential of the nanoparticulate cytosolic protein delivery carrier. Biochem. Biophys. Res. Commun. 366: 408-413. (Pubitemid 50010411)
12. Zhou, F., and L. Huang. 1995. Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway. J. Drug Target. 3: 91-109.
13. Watts, C. 1997. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15: 821-850. (Pubitemid 27169300)
14. Shen, Z., G. Reznikoff, G. Dranoff, and K. L. Rock. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158: 2723-2730. (Pubitemid 127470530)
15. Pfeifer, J. D., M. J. Wick, R. L. Roberts, K. Findlay, S. J. Normark, and C. V. Harding. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361: 359-362. (Pubitemid 23041629)
16. Harding, C. V., and R. Song. 1994. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153: 4925-4933. (Pubitemid 24356123)
17. Li, Y., Y. Ke, P. D. Gottlieb, and J. A. Kapp. 1994. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation. J. Leukoc. Biol. 56: 616-624. (Pubitemid 24348822)
18. Sampath, P., and T. D. Pollard. 1991. Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. Biochemistry 30: 1973-1980.
19. Rejman, J., V. Oberle, I. S. Zuhorn, and D. Hoekstra. 2004. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377: 159-169. (Pubitemid 38114443)
20. Swanson, J. A. 2008. Shaping cups into phagosomes and macropinosomes. Nat. Rev. Mol. Cell Biol. 9: 639-649.
21. Trombetta, E. S., and I. Mellman. 2005. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23: 975-1028. (Pubitemid 40563191)
22. Tran, K. K., and H. Shen. 2009. The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells. Biomaterials 30: 1356-1362.
23. Hansen, S. H., K. Sandvig, and B. van Deurs. 1993. Clathrin and HA2 adaptors: effects of potassium depletion, hypertonic medium, and cytosol acidification. J. Cell Biol. 121: 61-72. (Pubitemid 23097362)
24. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78: 773-785. (Pubitemid 24294453)
25. Meng, L., R. Mohan, B. H. Kwok, M. Elofsson, N. Sin, and C. M. Crews. 1999. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity. Proc. Natl. Acad. Sci. USA 96: 10403-10408. (Pubitemid 29422570)
26. Libby, P., and A. L. Goldberg. 1978. Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles. Science 199: 534-536. (Pubitemid 8298032)
27. Watts, C. 2001. Antigen processing in the endocytic compartment. Curr. Opin. Immunol. 13: 26-31. (Pubitemid 32096956)
28. Monu, N., and E. S. Trombetta. 2007. Cross-talk between the endocytic pathway and the endoplasmic reticulum in cross-presentation by MHC class I molecules. Curr. Opin. Immunol. 19: 66-72. (Pubitemid 46073703)
29. Jensen, P. E. 2007. Recent advances in antigen processing and presentation. Nat. Immunol. 8: 1041-1048. (Pubitemid 47423752)
30. Shen, L., and K. L. Rock. 2006. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr. Opin. Immunol. 18: 85-91. (Pubitemid 43049653)
31. Rock, K. L., and L. Shen. 2005. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207: 166-183. (Pubitemid 41415016)
32. Ackerman, A. L., C. Kyritsis, R. Tampé, and P. Cresswell. 2005. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat. Immunol. 6: 107-113. (Pubitemid 40136702)
33. Ackerman, A. L., and P. Cresswell. 2004. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5: 678-684. (Pubitemid 39023296)
34. Mu, F. T., J. M. Callaghan, O. Steele-Mortimer, H. Stenmark, R. G. Parton, P. L. Campbell, J. McCluskey, J. P. Yeo, E. P. Tock, and B. H. Toh. 1995. EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif. J. Biol. Chem. 270: 13503-13511.
35. Vonderheit, A., and A. Helenius. 2005. Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes. PLoS Biol. 3: e233.
36. Feng, Y., B. Press, and A. Wandinger-Ness. 1995. Rab 7: an important regulator of late endocytic membrane traffic. J. Cell Biol. 131: 1435-1452. (Pubitemid 26001749)
37. Sheff, D., L. Pelletier, C. B. O'Connell, G. Warren, and I. Mellman. 2002. Transferrin receptor recycling in the absence of perinuclear recycling endosomes. J. Cell Biol. 156: 797-804. (Pubitemid 34839863)
38. Kuznetsov, G., L. B. Chen, and S. K. Nigam. 1994. Several endoplasmic reticulum stress proteins, including ERp72, interact with thyroglobulin during its maturation. J. Biol. Chem. 269: 22990-22995. (Pubitemid 24283276)
39. Vassilakos, A., M. F. Cohen-Doyle, P. A. Peterson, M. R. Jackson, and D. B. Williams. 1996. The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. EMBO J. 15: 1495-1506. (Pubitemid 26112371)
40. Touret, N., P. Paroutis, M. Terebiznik, R. E. Harrison, S. Trombetta, M. Pypaert, A. Chow, A. Jiang, J. Shaw, C. Yip, et al. 2005. Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell 123: 157-170. (Pubitemid 41414536)
41. Cresswell, P., A. L. Ackerman, A. Giodini, D. R. Peaper, and P. A. Wearsch. 2005. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 207: 145-157. (Pubitemid 41415014)
42. Houde, M., S. Bertholet, E. Gagnon, S. Brunet, G. Goyette, A. Laplante, M. F. Princiotta, P. Thibault, D. Sacks, and M. Desjardins. 2003. Phagosomes are competent organelles for antigen cross-presentation. Nature 425: 402-406. (Pubitemid 37187269)
43. Guermonprez, P., L. Saveanu, M. Kleijmeer, J. Davoust, P. Van Endert, and S. Amigorena. 2003. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425: 397-402. (Pubitemid 37187268)
44. Rapoport, T. A. 2007. Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes. Nature 450: 663-669. (Pubitemid 350207698)
45. Ackerman, A. L., A. Giodini, and P. Cresswell. 2006. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 25: 607-617. (Pubitemid 44529035)
46. Imai, J., H. Hasegawa, M. Maruya, S. Koyasu, and I. Yahara. 2005. Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells. Int. Immunol. 17: 45-53.
47. Li, P., J. L. Gregg, N. Wang, D. Zhou, P. O'Donnell, J. S. Blum, and V. L. Crotzer. 2005. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing. Immunol. Rev. 207: 206-217. (Pubitemid 41415019)
48. Medina-Kauwe, L. K. 2007. "Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery? Adv. Drug Deliv. Rev. 59: 798-809. (Pubitemid 47320815)
49. Gagnon, E., S. Duclos, C. Rondeau, E. Chevet, P. H. Cameron, O. Steele-Mortimer, J. Paiement, J. J. Bergeron, and M. Desjardins. 2002. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110: 119-131. (Pubitemid 34874611)